AR014939A1 - Proceso para purificar una solucion de un ester profarmaco de ampicilina - Google Patents

Proceso para purificar una solucion de un ester profarmaco de ampicilina

Info

Publication number
AR014939A1
AR014939A1 ARP980106240A ARP980106240A AR014939A1 AR 014939 A1 AR014939 A1 AR 014939A1 AR P980106240 A ARP980106240 A AR P980106240A AR P980106240 A ARP980106240 A AR P980106240A AR 014939 A1 AR014939 A1 AR 014939A1
Authority
AR
Argentina
Prior art keywords
ester
formula
solution
profarmac
ampicilin
Prior art date
Application number
ARP980106240A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9704868A external-priority patent/SE9704868D0/xx
Priority claimed from SE9800255A external-priority patent/SE9800255D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR014939A1 publication Critical patent/AR014939A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/18Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Proceso para purificar una solucion de un éster profármaco de ampicilina, de la formula (I): en la cual R es igual a formula (II) y R1 es igual a una delgrupo (III) o las sales de adicion de ácido del mismo; de contaminantes que se originan en laela boracion del mismo, especialmente para eliminar la baseempleada al incorporar el grupo R en dicho éster de la formula (I), como ser del correspondiente éster en el cual R es fenilacetilo, caracterizado porqueincluye un paso en el cual se sometea una solucion cruda de dicho éster profármaco de ampicilina de la formula (I), o una sal de adicion de ácido del mismo,en un solvente orgánico para ese fin, a una evaporacion controlada por la tasa de evaporacion del solvente orgánico de tal maneraque s e obtiene una operacioncontinua para la cristalizacion del éster profármaco purificado, o sal del mismo. Dicha cristalizacion se realiza preferentemente con posterioridad a unaextraccion con fase acuosa y/o una extraccion con fase orgánica,realizánd ose ambas, preferentemente, asimismo en forma continua.
ARP980106240A 1997-12-22 1998-12-09 Proceso para purificar una solucion de un ester profarmaco de ampicilina AR014939A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704868A SE9704868D0 (sv) 1997-12-22 1997-12-22 New process
SE9800255A SE9800255D0 (sv) 1998-01-29 1998-01-29 New process

Publications (1)

Publication Number Publication Date
AR014939A1 true AR014939A1 (es) 2001-04-11

Family

ID=26663170

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106240A AR014939A1 (es) 1997-12-22 1998-12-09 Proceso para purificar una solucion de un ester profarmaco de ampicilina

Country Status (21)

Country Link
US (1) US6414141B1 (es)
EP (1) EP1049702B1 (es)
JP (1) JP2001526291A (es)
KR (1) KR20010024788A (es)
CN (1) CN1284959A (es)
AR (1) AR014939A1 (es)
AU (1) AU741292B2 (es)
BR (1) BR9814388A (es)
CA (1) CA2315082A1 (es)
DZ (1) DZ2687A1 (es)
EE (1) EE200000389A (es)
EG (1) EG21726A (es)
HU (1) HUP0100403A3 (es)
IL (1) IL136879A0 (es)
IS (1) IS5530A (es)
MA (1) MA26578A1 (es)
NO (1) NO20002988L (es)
NZ (1) NZ505166A (es)
TN (1) TNSN98228A1 (es)
TR (1) TR200001858T2 (es)
WO (1) WO1999032493A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7463626B2 (en) * 2000-11-21 2008-12-09 Roy Subhash C Phase and frequency drift and jitter compensation in a distributed telecommunications switch
US20040215003A1 (en) * 2002-11-12 2004-10-28 Dobbins Thomas A. Method for purifying and separating soy isoflavones
CN102284192B (zh) * 2011-06-16 2013-06-12 北京科技大学 并、逆流耦合式连续反萃青霉素设备及工艺
KR20230056433A (ko) 2021-10-20 2023-04-27 현대자동차주식회사 전자기판용 보호코팅 조성물 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905959A (en) * 1973-05-07 1975-09-16 Pfizer Process for the manufacture of crystalline anhydrous ampicillin
NZ189945A (en) 1978-04-01 1981-04-24 Beecham Group Ltd Ampicillin phthalidyl ester naphthalene 2-sulphonate also pharmaceutical compositions
IL67637A0 (en) * 1983-01-07 1983-05-15 Orvet Bv Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins and novel intermediates
IT1214587B (it) * 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.

Also Published As

Publication number Publication date
TR200001858T2 (tr) 2000-10-23
EG21726A (en) 2002-02-27
WO1999032493A1 (en) 1999-07-01
AU1990399A (en) 1999-07-12
AU741292B2 (en) 2001-11-29
MA26578A1 (fr) 2004-12-20
NZ505166A (en) 2002-02-01
KR20010024788A (ko) 2001-03-26
DZ2687A1 (fr) 2003-03-29
BR9814388A (pt) 2000-10-10
JP2001526291A (ja) 2001-12-18
TNSN98228A1 (fr) 2005-03-15
EP1049702A1 (en) 2000-11-08
NO20002988D0 (no) 2000-06-09
IS5530A (is) 2000-06-13
CN1284959A (zh) 2001-02-21
EE200000389A (et) 2001-12-17
US6414141B1 (en) 2002-07-02
IL136879A0 (en) 2001-06-14
EP1049702B1 (en) 2003-03-19
HUP0100403A2 (hu) 2001-08-28
CA2315082A1 (en) 1999-07-01
HUP0100403A3 (en) 2001-12-28
NO20002988L (no) 2000-06-09

Similar Documents

Publication Publication Date Title
AR068527A2 (es) Un procedimiento para preparar monohidrato de bromuro de tiotropio cristalino
BRPI0520252A2 (pt) método de desacilar sucralose-6-éster
PE1299A1 (es) Procedimiento para la preparacion de sildenafil
PE20061014A1 (es) Clorhidrato de lercanidipina amorfo
FR2844209B1 (fr) Procede de purification par nanofiltration d'une solution aqueuse sucree contenant des anions et cations monovalents et polyvalents
AR070109A1 (es) Metodo para sintetizar tetrahidobiopterina
ECSP093680A (es) Proceso para derivados del acido fenilacetico
ES2923623T3 (es) Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
NZ592385A (en) Highly purified polylactic acid or a derivative thereof, a salt of the same, and purification method thereof
ES2096933T3 (es) Compuesto capaz de permanecer en la region intracerebral y utilizacion del mismo.
AR014939A1 (es) Proceso para purificar una solucion de un ester profarmaco de ampicilina
IL195622A0 (en) Process for the purification of montelukast
ES2140027T3 (es) P-isopropilbenceno-sulfonato de valina y un procedimiento para purificar valina.
CO5611115A2 (es) Proceso para la produccion de propionato de fluticasona, en particular de la forma polimorfica 1
AR029002A1 (es) Proceso para preparar compuestos de acidos quinolin-2-carboxilicos y de sus sales farmaceuticamente aceptables
ATE266020T1 (de) Synthese von r-(+)-alpha-liponsäure
ATE373667T1 (de) Verfahren zur herstellung von ceftiofur
CU23171A3 (es) Procedimiento para la preparacion de sal de calcio de zofenopril
AR036018A1 (es) Proceso para aislar monohidrato de imipenem cristalino puro
DK1200436T3 (da) Fremgangsmåde til fremstilling af rene stereoisomerer af tetrahydrofolsyreestersalte og tetrahydrofolsyre ved fraktioneret krystallisering af tetrahydrofolsyreestersalte
ES2195925T3 (es) Proceso para fabricar una formulacion de liberacion retardada.
FR2409252A1 (fr) Procede de purification de l'acide p-tolylique obtenu par oxydation du p-xylene
DE50001372D1 (de) Verfahren zur Reinigung von Kreatin
AR087993A1 (es) Procesos e intermediarios para la preparacion de un inhibidor macrociclico de la proteasa del hcv
GB2418916A (en) Process for purifying citalopram using polybasic acids

Legal Events

Date Code Title Description
FA Abandonment or withdrawal